/HELX
HELX Stock - Franklin Genomic Advancements ETF
Financial Services|Asset ManagementCBOE
$36.44+1.06%
+$0.38 (+1.06%) • Dec 19
69
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.83
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.68
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $40.08
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for HELX
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$36.08 – $36.80
TARGET (TP)$41.91
STOP LOSS$33.52
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.29
52W High$38.11
52W Low$23.74
Avg VolumeN/A
Income Statement (Fiscal Year)
Loading financial data...
Company Overview
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.
Loading analyst ratings...
Earnings History & Surprises
HELXLoading earnings data...
Latest News
Loading news...
Frequently Asked Questions about HELX
What is HELX's current stock price?
Franklin Genomic Advancements ETF (HELX) is currently trading at $36.44 per share. The stock has moved +1.06% today.
What is the analyst price target for HELX?
No analyst price targets are currently available for this stock.
What sector is Franklin Genomic Advancements ETF in?
Franklin Genomic Advancements ETF operates in the Financial Services sector, specifically within the Asset Management industry. The company is traded on the CBOE exchange.
What is HELX's market cap?
Franklin Genomic Advancements ETF has a market capitalization of $0.02 billion, making it a small-cap company.
Does HELX pay dividends?
No, Franklin Genomic Advancements ETF does not currently pay a dividend to shareholders.
Similar Stocks
Financial Services SectorBWTG
Brendan Wood TopGun ETF
$38.87
Mkt Cap: $0.0B
BYRE
Principal Real Estate Active Opportunities ETF
$24.44
Mkt Cap: $0.0B
DGIN
VanEck Digital India ETF
$43.24
Mkt Cap: $0.0B
FMKT
The Free Markets ETF
$22.36
Mkt Cap: $0.0B
MEDX
Horizon Kinetics Medical ETF
$33.58
Mkt Cap: $0.0B
QRMI
Global X NASDAQ 100 Risk Managed Income ETF
$16.14
Mkt Cap: $0.0B
RHRX
RH Tactical Rotation ETF
$18.42
Mkt Cap: $0.0B
RW
Rainwater Equity ETF
$24.89
Mkt Cap: $0.0B
UCC
ProShares Ultra Consumer Services
$54.34
Mkt Cap: $0.0B
XTJL
Innovator U.S. Equity Accelerated Plus ETF - July
$38.74
Mkt Cap: $0.0B
Explore stocks similar to HELX for comparison